GS
VXRT

GTS Securities’s Vaxart VXRT Stock Holding History

GTS Securities’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,400
Closed -$8.27K – 4483
2024
Q2 		$8.27K Buy
+12,400
New +$10.3K ﹤0.01% 3822

Other funds holding VXRT

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GTS Securities's VXRT Position: Q4 2024 in Review

GTS Securities sold out of Vaxart (VXRT) in Q4 2024, closing a stake of 32,670 shares — an estimated $27.7K sold.

GTS Securities first reported a position in VXRT in Q1 2024 and held it in 3 quarters. The position peaked at $32K in Q2 2024. 93 funds tracked by Wall St. Rank hold VXRT as of Q4 2024.

  • GTS Securities reported no remaining Vaxart position as of Q4 2024 after selling out during the quarter.
  • GTS Securities sold 32,670 Vaxart shares in Q4 2024, an estimated $27.7K.
  • GTS Securities first reported a position in Vaxart in Q1 2024 and held it in 3 quarters.
  • GTS Securities's Vaxart position peaked at $32K in Q2 2024.
  • 93 funds tracked by Wall St. Rank held Vaxart as of Q4 2024.

Based on GTS Securities's 13F filing for Q4 2024, filed 18 Feb 2025.